Speech and voice disorders negatively impact people with Parkinson's Disease (PD) Between 85 and 90% of individuals with PD develop voice and speech disorders during the course of their illness.

An artificial intelligence recreation of legendary British interviewer Sir Michael Parkinson will host a groundbreaking new ...

Dr. Torres-Yaghi speaks at monthly support group, weekly Rock Steady Boxing reaching area residents living with fastest ...

Pictured are some of the members of the Sterling Lions Club Parkinson’s Exercise Group. Because exercise is known to be the best treatment for Parkinson’s Disease, the Lions group decided to ...

She still plays her mandolin. Led by Kelly Haber and April Dayok, the New Orleans Ballet Association's Dancing for Parkinson's class brings movement, exercise and community to people with ...

Northern Arizona University (NAU) is offering a free weekly movement class this fall for those dealing with Parkinson’s disease. Parkinson’s is a chronic progressive brain disorder that can ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers ...

Voice of the late Sir Michael Parkinson has been recreated by AI for a podcast. Virtually Parkinson will be an unscripted show featuring interviews with guests. It has the backing of Sir ...

The project ... Automatic Speech Recognition (ASR) for speakers with unique speech patterns resulting from conditions such as Cerebral Palsy, ALS, stroke, Down Syndrome, or Parkinson's.

Veteran BBC presenter John Stapleton has revealed Parkinson’s disease has “frustratingly ... Stapleton said: “My voice has lost a lot of its relevance. “I am seeing a speech therapist, but it is very ...

Google Research Africa, the University of Ghana, and UCL’s Global Disability Innovation Hub (GDI Hub) are joining forces on Project Euphonia.

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...